The Ensign Group (ENSG) Acquires Riverbend, Shares Up
Zacks Equity Research - Zacks Investment Research - Thu Jul 07, 3:52PM CDT
The Ensign Group Inc. (ENSG) recently acquired Kansas City-based Riverbend Post Acute Rehabilitation.
ENSG: 21.60 (+0.23), ABMD: 115.94 (+1.79), ABCO: 38.09 (+0.67), BEAT: 17.50 (+0.96)
Cooper Companies Strong on Portfolio Expansion Plans
Zacks Equity Research - Zacks Investment Research - Wed Jul 06, 8:38AM CDT
The Cooper Companies Inc. (COO) is firing on all cylinders, buoyed by its expanding product portfolio and consistent earnings results.
BSX: 23.77 (-0.13), JNJ: 122.93 (+0.08), BEAT: 17.50 (+0.96), COO: 182.10 (+0.27)
PAREXEL's (PRXL) Updated Long-term View Raises Hope
Zacks Equity Research - Zacks Investment Research - Tue Jul 05, 7:41AM CDT
PAREXEL International Corporation (PRXL) recently provided an update on its long-term growth trends.
PRXL: 66.16 (-0.04), HQY: 31.23 (+0.30), BEAT: 17.50 (+0.96), AHS: 43.14 (+0.46)
ICON (ICLR) Set to Acquire Clinical Research Management
Zacks Equity Research - Zacks Investment Research - Fri Jul 01, 7:34AM CDT
ICON Plc (ICLR) recently announced plans to acquire Clinical Research Management Inc. for an undisclosed sum.
EVHC: 26.00 (+0.30), BEAT: 17.50 (+0.96), AHS: 43.14 (+0.46), ICLR: 73.15 (+0.40)
42.6% Return Seen to Date on SmarTrend CardioNet Call (BEAT)
Comtex SmarTrend(R) - Wed Jun 15, 12:18AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 4 months, CardioNet has returned 42.64% as of today's recent price of $15.99.
BEAT: 17.50 (+0.96)
HealthEquity Q1 Earnings Top, Revenues Rise Y/Y; View Up
Zacks Equity Research - Zacks Investment Research - Wed Jun 08, 7:35AM CDT
Shares of HealthEquity Inc (HQY) increased almost 4% in after-hours following impressive first-quarter fiscal 2017 results.
AIRM: 38.33 (+0.51), HQY: 31.23 (+0.30), BEAT: 17.50 (+0.96), AHS: 43.14 (+0.46)
The Zacks Analyst Blog Highlights: Entercom Communications, BioTelemetry, First Majestic Silver, BG Staffing and Orrstown Financial Services
Zacks Equity Research - Zacks Investment Research - Tue May 31, 8:30AM CDT
The Zacks Analyst Blog Highlights: Entercom Communications, BioTelemetry, First Majestic Silver, BG Staffing and Orrstown Financial Services
ETM: 14.08 (+0.19), AG: 16.45 (+0.48), BEAT: 17.50 (+0.96), BGSF: 21.05 (+0.40), ORRF: 17.87 (-0.08)
Shares of BEAT Up 52.2% Since Uptrend Call on Shares
Comtex SmarTrend(R) - Tue May 31, 12:15AM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 3 months, CardioNet has returned 52.19% as of today's recent price of $17.06.
BEAT: 17.50 (+0.96)
5 Breakout Stocks Under $20
Zacks Equity Research - Zacks Investment Research - Fri May 27, 11:15AM CDT
The breakout strategy is probably the most commonly used one by active investors.
ETM: 14.08 (+0.19), AG: 16.45 (+0.48), BEAT: 17.50 (+0.96), BGSF: 21.05 (+0.40), ORRF: 17.87 (-0.08)
Medical Service Stocks Should be on your Buying Radar
Zacks Premium Research - Zacks Investment Research - Wed May 25, 3:47PM CDT
Investing in this industry now could pay off for you over the short term.
HQY: 31.23 (+0.30), BEAT: 17.50 (+0.96), AHS: 43.14 (+0.46)
Uptrend Call Working As CardioNet Stock Rises 36.5% (BEAT)
Comtex SmarTrend(R) - Mon May 23, 12:56PM CDT
SmarTrend identified an Uptrend for CardioNet (NASDAQ:BEAT) on February 18th, 2016 at $11.21. In approximately 3 months, CardioNet has returned 36.53% as of today's recent price of $15.31.
BEAT: 17.50 (+0.96)
Waters Corp. Expands Xevo Line with Xevo TQ-XS Launch
Zacks Equity Research - Zacks Investment Research - Tue May 17, 8:44AM CDT
Waters Corporation (WAT) expanded its portfolio of Xevo mass spectrometers with the launch of Xevo TQ-XS mass spectrometer, which is arguably the most sensitive instrument of its kind in the market.
BEAT: 17.50 (+0.96), BRKR: 24.35 (+0.67), PKI: 53.96 (+0.01), WAT: 145.78 (-0.75)
BioTelemetry, Inc. Announces the Completion of Its Acquisition of VirtualScopics, Inc.
GlobeNewswire - Wed May 11, 8:25AM CDT
BioTelemetry, Inc. (NASDAQ:BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that it has completed its acquisition of VirtualScopics, Inc. (NASDAQ:VSCP), a leading provider of clinical trial imaging solutions. The acquisition comes after the successful completion of the all cash tender offer for all outstanding common and preferred shares of VirtualScopics. The total purchase consideration was approximately $15.0 million, net of cash and debt acquired.
VSCP: 4.04 (+0.01), BEAT: 17.50 (+0.96)
BioTelemetry, Inc. Announces Results of Tender Offer for Shares of VirtualScopics, Inc.
GlobeNewswire - Tue May 10, 7:05AM CDT
BioTelemetry, Inc. (NASDAQ: BEAT), the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today that the tender offer of its wholly owned subsidiary, BioTelemetry Research Acquisition Corporation ("Offeror"
VSCP: 4.04 (+0.01), BEAT: 17.50 (+0.96)
BioTelemetry, Inc. Appoints Colin Hill to Its Board of Directors
GlobeNewswire - Fri May 06, 3:05PM CDT
BioTelemetry, Inc. (NASDAQ:BEAT) the leading wireless medical technology company focused on the delivery of health information to improve quality of life and reduce cost of care, announced today the appointment of Colin Hill to its Board of Directors.
BEAT: 17.50 (+0.96)
Can The Uptrend Continue for BioTelemetry (BEAT)?
Zacks Equity Research - Zacks Investment Research - Fri May 06, 8:03AM CDT
Investors certainly have to be happy with BioTelemetry, Inc. (BEAT) and its short term performance.
BEAT: 17.50 (+0.96)
Why BioTelemetry (BEAT) Stock Might be a Great Pick
Zacks Equity Research - Zacks Investment Research - Wed May 04, 7:39AM CDT
BioTelemetry (BEAT) is seeing solid earnings estimate revision activity, and is in great company from a Zacks Industry Rank perspective.
BEAT: 17.50 (+0.96)